
Yilinyun is a medical and life-tech firm providing an integrated cloud SaaS platform for clinical evidence to improve R&D in drugs listing.
LinkedInUpdated Aug 10, 2026
Yilinyun revenue
Yilinyun's annual revenue was $392K in December 2021 (source not recorded). The company has since shut down.
$0
$100K
$200K
$300K
$0
$392K
2021Dec 2021
| As of | Revenue | Source |
|---|---|---|
| Dec 2021 | $392K | – |
– source not recorded
Yilinyun CEO, founders & employees
LONG QIN founded Yilinyun in 2021 and led it as CEO. Yilinyun had 4 employees (December 2021).
- LONG QINFounder & CEO
0
1
2
3
4
4
2021
Yilinyun FAQ
Browse Clinical Research Software
- Keylabs AI$392K
- Unpickle$391.6K
- Perfarm$394.3K
- Bluerocktel$389.6K
- Taprint$396K
- GearBrain$397K
- ConfigWorkbook$386.1K
- Crowdskout$386K
- countify GmbH$385.6K
- Cardiolyse$384.1K
- FabMetrics$383.8K
- Social Elephants$382.5K
- Sampoh$404.6K
- Metigy$408.1K
- SpikeFli Analytics$409.6K
- Funkeyads$412.3K
- Cognitiv+$371.1K
- Chantico Technology, Inc.$420K
- Morningscore$420K
- JOPO AI$420K
How this page is sourced
Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Aug 10, 2026Data disclaimerReport a correction